Elisabeth Kolar

Elisabeth Kolar currently serves as a Deviation Writer at Osmotica Pharmaceutical Corp. since October 2023. Prior to this role, Elisabeth worked at Societal™ CDMO (formerly Recro) as a QC Analyst III and QC Analyst II from September 2019 to June 2023. Elisabeth also held a position as an Associate Research Scientist at Alcon from November 2018 to May 2019, focusing on analytical and physical analyses of materials related to contact lenses. Before that, Elisabeth spent six years at Endo Pharmaceuticals, where the career began as a QC Chemist and progressed through various chemist positions, including certified trainer for laboratory compliance. Elisabeth's educational background includes a Bachelor of Science in Biochemistry with a minor in Biology from The University of Tennessee at Chattanooga, completed in 2012.